Page last updated: 2024-11-01

nifedipine and Apolipoprotein B-100, Familial Defective

nifedipine has been researched along with Apolipoprotein B-100, Familial Defective in 1 studies

Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.

Research Excerpts

ExcerptRelevanceReference
"Treatment with nifedipine completely restored 5-HT-induced vasodilation (113 +/- 13%), whereas it did not influence basal forearm vasomotion or SNP-induced vasodilation."1.30Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids. ( Honing, ML; Kastelein, JJ; Koomans, HA; Rabelink, TJ; van Dam, T; Verhaar, MC; Zwart, M, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Verhaar, MC1
Honing, ML1
van Dam, T1
Zwart, M1
Koomans, HA1
Kastelein, JJ1
Rabelink, TJ1

Other Studies

1 other study available for nifedipine and Apolipoprotein B-100, Familial Defective

ArticleYear
Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids.
    Cardiovascular research, 1999, Volume: 42, Issue:3

    Topics: Adult; Calcium Channel Blockers; Case-Control Studies; Cells, Cultured; Endothelium, Vascular; Femal

1999